Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-26T06:12:00.541Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevalent serotypes of Bordetella pertussis in non-vaccinated communities

Published online by Cambridge University Press:  15 May 2009

Noel W. Preston
Noel W. Preston
Affiliation:
Department of Bacteriology and Virology, University of Manchester, Manchester M13 9PT
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In many countries, the prevalent serotypes of Bordetella pertussis have changed from a mixture of types 1,2,3 and 1,2 (organisms possessing antigen 2) to a predominance of type 1,3. The timing of the change in different countries is shown to be related to the introduction of mass-vaccination with material rich in antigens 1 and 2 but weak in, or devoid of, antigen 3. In several parts of the world, there have been outbreaks of type 1,3 infection in fully vaccinated children.

Non-vaccinated communities in various parts of the world still show the pattern of serotypes which existed elsewhere before mass-vaccination.

In order to avoid the disappointments experienced in the past, it is essential that pertussis vaccine for use in previously non-vaccinated communities, like that for any other country, should be rich in each of the three antigens.

Type
Research Article
Information
Journal of Hygiene , Volume 77 , Issue 1 , August 1976 , pp. 85 - 91
Copyright
Copyright © Cambridge University Press 1976

References

REFERENCES

Aftandelians, R. V. & Connor, J. D. (1974). Bordetella pertussis serotypes in a whooping cough outbreak. American Journal of Epidemiology 99, 343–6.CrossRefGoogle Scholar
Agarwal, K. C. & Preston, N. W. (1976). Pertussis agglutinins in vaccinated mice: difficulty in estimating the type specific response. Indian Journal of Medical Research 64, 393–8.Google ScholarPubMed
Andersen, E. K. (1953). Serological studies on H. pertussis, H. parapertussis and H. bronchisepticus. Acta pathologica et microbiologica scandinavica 33, 202–24.CrossRefGoogle Scholar
Blaskett, A. C., Gulasekharam, J. & Fulton, L. C. (1971). The occurrence of Bordetella pertussis serotypes in Australia. 1950–1970. The Medical Journal of Australia i, 781–4.CrossRefGoogle Scholar
Chalvardjian, N. (1965). The content of antigens 1, 2 and 3 in strains of Bordetella pertussis and in vaccines. The Canadian Medical Association Journal 92, 1114–16.Google ScholarPubMed
Cohen, H. (1970). Effectiveness of pertussis vaccination in the Netherlands. In International Symposium on Pertussis, Bilthoven 1969. Symposia Series in Immunobiological Standardization, Vol. 13, pp. 10–13. Basel: Karger.Google Scholar
Cohen, H. H., Hannik, C. A. & Nagel, J. (1971). Success and limitations of vaccination against pertussis. Scientific Publication no. 226, pp. 323–8. Washington D.C.: Pan American Health Organization.Google Scholar
Demina, A. A., Larina, L. I. & Devyatkina, N. P. (1968). A change of the serological type of pertussis causative agent. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii no 2, pp. 13–17.Google Scholar
Eldering, G., Holwerda, J., Davis, A. & Baker, J. (1969). Bordetella pertussis serotypes in the United States. Applied Microbiology 18, 618–21.CrossRefGoogle ScholarPubMed
Kuznetsov, E. A. (1972). Concerning the antigenic structure of B. pertussis and its association with conditions of the strain circulation. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii no. 9, pp. 122–7.Google Scholar
Lacey, B. W. (1960). Antigenic modulation of Bordetella pertussis. Journal of Hygiene 58, 57–93.CrossRefGoogle ScholarPubMed
Perkins, F. T. (1969). Vaccination against whooping-cough. British Medical Journal iv, 429–30.CrossRefGoogle Scholar
Preston, N. W. (1963). Type-specific immunity against whooping-cough. British Medical Journal ii, 724–6.CrossRefGoogle Scholar
Preston, N. W. (1965 a). Effectiveness of pertussis vaccines. British Medical Journal ii, 11–13.CrossRefGoogle Scholar
Preston, N. W. (1965 b). Whooping-cough. British Medical Journal ii, 1001.CrossRefGoogle Scholar
Preston, N. W. (1966). The natural selection of resistant bacteria in an artifically immunized human population. Abstracts of Papers IX International Congress for Microbiology Moscow,July 1966, p. 695. Organizing Committee of the Congress. Institute of Virology, Moscow.Google Scholar
Preston, N. W. (1970 a). Pertussis: the epidemiological situation in various countries – serotypes. In International Symposium on Pertussis Bilthoven 1969. Symposia Series in Immunobiological Standardization, Vol. 13, pp. 18–20. Basel: Karger.Google Scholar
Preston, N. W. (1970 b). Technical problems in the laboratory diagnosis and prevention of whooping-cough. Laboratory Practice 19, 482–6.Google ScholarPubMed
Preston, N. W. (1973). Efficacy of whooping-cough vaccines. British Medical Journal ii, 485–6.CrossRefGoogle Scholar
Preston, N. W. (1976). Protection by pertussis vaccine: little cause for concern. Lancet i, 1065–7.CrossRefGoogle Scholar
Preston, N. W.Mackay, R. I., Bamford, F. N., Crofts, J. E. & Burland, W. L. (1974). Pertussis agglutinins in vaccinated children: better response with adjuvant. Journal of Hygiene 73, 119–25.CrossRefGoogle ScholarPubMed
Preston, N. W. & Stanbridge, T. N. (1976). Mouse or man? Which are pertussis vaccines to protect? Journal of Hygiene 76, 249–56.CrossRefGoogle ScholarPubMed
Public Health Laboratory Service (1969). Efficacy of whooping-cough vaccines used in the United Kingdom before 1968. British Medical Journal iv, 329–33.Google Scholar
Shmilovitz, M., Preston, N. W., Zaltser, H. & Cahana, A. (1972). Whooping cough in northern Israel. Israel Journal of Medical Sciences 8, 1936–9.Google ScholarPubMed
Stanbridge, T. N. & Preston, N. W. (1974 a). Variation of serotype in strains of Bordetella pertussis. Journal of Hygiene 73, 305–10.CrossRefGoogle ScholarPubMed
Stanbridge, T. N. & Preston, N. W. (1974 b). Experimental pertussis infection in the marmoset: type specificity of active immunity. Journal of Hygiene 72, 213–28.CrossRefGoogle ScholarPubMed
Walter, T. (1968). Zum Problem der Keuchhustenimpfungen. Zentralblatt für Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene I Orig. 206, 131–2.Google Scholar